Ginkgo Datapoints and Apheris Launch Antibody Developability Consortium, Ginkgo to Run AbDev AI Competition

Ginkgo Datapoints and Apheris have partnered to form the Antibody Developability Consortium, which aims to address the challenge of predicting and optimizing antibody properties early in the research and development process. The consortium combines Ginkgo's high-throughput experimental capabilities for generating AI-ready datasets with Apheris's federated computing infrastructure, allowing members to securely collaborate on sensitive data.

One2Treat raises capital to further accelerate software platform development and relocates offices to support rapid growth

One2Treat SA, a fast-growing technology company transforming how the patient voice is integrated into clinical development, announced today the successful completion of a planned seed extension to accelerate its software platform development.

Symbiosis Expands Quality Leadership with New Qualified Person Appointment

Onvida Health and Ambience Healthcare Launch Frontier Ambient AI Capabilities Inside Epic

Elsevier launches PharmaPendium AI, to accelerate access to regulatory data for drug development

Elsevier launches PharmaPendium AI - a generative AI assistant for regulatory intelligence in drug development.

MultiOmic Health and BIO4 Campus Sign MoU to Advance Precision Medicine and Support Bioeconomy Growth in Serbia

MultiOmic Health Limited (“MOH”), an artificial intelligence (AI)-enabled precision medicine biotechnology company, and BIO4 Campus (“BIO4”), the Republic of Serbia's flagship biotechnology and life sciences hub, today announced the signing of a Memorandum of Understanding (MoU) to explore collaborative opportunities in biomedicine, biotechnology and bioinformatics, with a strong emphasis on AI applications.

EpiCypher Launches Fiber-seq, a Breakthrough Multiomic Single-Molecule Genomics Assay

Ametris expands collaborative research project to investigate digital measures of physical function for drug development in obesity

Ametris (formerly ActiGraph), a global digital health solutions provider transforming real-world patient data into validated clinical evidence, announced the launch of Digital Endpoint Collaboration to accelerate Outcome DEvelopment (DECODE) in Obesity.

CN Bio adds computational modeling capabilities to ADME services for enhanced bioavailability profiling

• New PhysioMimix in silico tools unlock deeper functional insights from existing assays, advancing translation of MPS data to predict human ADME behavior • End-to-end support from experimental design to data interpretation

Quotient Sciences and CPI to Accelerate RNA Drug Development with Joint Venture

PhenoTips Receives the Life Sciences Innovation Fund: The Ontario-based life sciences company was awarded $500,000 by the Ontario Centre of Innovation to support growth in the precision medicine marketplace

PhenoTips, based in Toronto, has developed a first-of-its-kind cloud-based software that streamlines and digitizes genomic health record management, saving clinicians time and supporting precision medicine initiatives. In June 2025, PhenoTips was one of 13 Ontario-based life sciences companies to receive the renewed Life Sciences Innovation Fund from the government of Ontario, through the Ontario Centre of Innovation (OCI).

Aptamer Group Introduces Novel Biomarker Discovery Service

Qureight’s AI 3D imaging platform to support Calluna Pharma’s Phase 2 AURORA study of CAL101 in Idiopathic Pulmonary Fibrosis (IPF)

• Qureight’s advanced AI 3D imaging platform to be used across clinical trial to evaluate anatomical lung changes in adult patients, including during patient enrolment • CAL101 is a first-in-class monoclonal antibody that neutralises the S100A4 protein, which is an upstream driver and amplifier of the multiple pro-fibrotic pathways active in IPF

Advancing regenerative medicine: Cellbricks Therapeutics reaches key milestone using Rousselot biomaterials

Rousselot announces promising preclinical results from a study conducted by Cellbricks Therapeutics, a Berlin-based biotech startup and spin-off from the Technical University of Berlin. As a pioneer in 3D-bioprinting, Cellbricks successfully implanted 3D-bioprinted adipose tissue constructs into mice, with no signs of fibrosis or rejection observed after seven weeks.

Hongene to supply exNA oligonucleotide technology under new licensing deal

DNAnexus Enhances Leadership to Fuel AI Innovation and Biopharma Expansion

Company appoints Pieter De Leenheer as Chief Technology Officer and Todd Oakland as Senior Vice President and General Manager of Biopharma Business Dx/Rx

Huateng Pharma Expands Cosmetic Ingredients Portfolio with Reliable, Ready-to-Ship Actives

Huateng Pharma offers reliable cosmetic ingredients including Diethylamino Hydroxybenzoyl Hexyl Benzoate, Tetrahydrocurcumin, and Piroctone Olamine.

eClinical Solutions Announces Integrated Data Review Plan (IDRP) Capabilities Within elluminate Platform

Company becomes the first to centralize digital data review activities within a single platform as the industry focuses on clinical trial efficiency

Tyra Biosciences Announces First Child Dosed in BEACH301, its Phase 2 Study for Dabogratinib (TYRA-300) in Pediatric Achondroplasia

ZeOmega Launches Smart Auth Optimizer to Transform Prior Authorization